Zomato cross-sells fitso to Curefit
The, now publicly listed, online food delivery company Zomato has sold Fitso to Curefit Healthcare for $50 million. The company also announced its plans to invest a cumulative $100 million in Curefit. As per a company blog post, “This will help us potentially explore cross-selling benefits between Zomato and Curefit, as we see food and health becoming the same side of the coin in the long term.”
Furthermore, Zomato has shut down its D2C Nutraceuticals. “Instead, we are choosing to back a platform play for all D2C brands (by investing in Shiprocket; more on this later). We are also shutting down our operations in Lebanon, which is the only international business we were left with (other than dining-out business in UAE) after shutting down the rest of our international operations last year,” said Zomato founder Deepinder Goyal.
Follow Startup Story
Related Posts
